Inactive Instrument

Analyst Reco. ASLAN Pharmaceuticals Limited Taipei Exchange

Equities

HC Wainwright Cuts ASLAN Pharmaceuticals Price Target to $9 From $17, Maintains Buy Rating	Mar. 18	MT
Piper Sandler Cuts ASLAN Pharmaceuticals' Price Target to $10 From $15, Maintains Overweight Rating	Mar. 13	MT
Roth MKM Initiates ASLAN Pharmaceuticals at Buy With $15 Price Target	23-05-31	MT
Piper Sandler Adjusts Price Target on ASLAN Pharmaceuticals to $3 From $4, Maintains Overweight Rating	23-02-27	MT
HC Wainwright Adjusts Price Target on ASLAN Pharmaceuticals to $4.50 From $7, Keeps Buy Rating	23-02-27	MT
Piper Sandler Adjusts Price Target on ASLAN Pharmaceuticals to $4 From $3, Reiterates Overweight Rating	22-09-16	MT
Piper Sandler Adjusts ASLAN Pharmaceuticals' Price Target to $3 from $8, Keeps Overweight Rating	22-05-23	MT
ASLAN PHARMACEUTICALS : Jefferies & Co Initiates Coverage on ASLAN Pharmaceuticals With Buy Rating, $8 Price Target	21-07-09	MT
ASLAN PHARMACEUTICALS : HC Wainwright Adjusts ASLAN Pharmaceuticals' Price Target to $8 from $5, Keeps Buy Rating	21-03-17	MT

No results for this search